Aricept Related Published Studies
Well-designed clinical trials related to Aricept (Donepezil)
The effects of counseling spouse caregivers of people with Alzheimer disease taking donepezil and of country of residence on rates of admission to nursing homes and mortality. [2009.09]
Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation. [2009.08.01]
The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome. [2009.08]
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. [2009.07.24]
Rates of Cognitive Change in Alzheimer Disease: Observations Across a Decade of Placebo-controlled Clinical Trials With Donepezil. [2009.06.25]
Donepezil delays progression to AD in MCI subjects with depressive symptoms. [2009.06.16]
Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease. [2009.06]
Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. [2009.05.05]
Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial. [2009.03]
A rapid and specific approach for direct measurement of donepezil concentration in human plasma by LC-MS/MS employing solid-phase extraction. [2009.02]
Donepezil treatment of patients with MCI. A 48-week randomized, placebo-controlled trial. [2009.01.28]
Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan. [2009]
A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia. [2008.12.12]
Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. [2008.09]
A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia. [2008.08.07]
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. [2008.07]
Effects of donepezil on verbal memory after semantic processing in healthy older adults. [2008.06]
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. [2008.05]
Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. [2008.03]
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. [2008.03]
Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil. [2008.01]
Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial. [2008]
Treatment of a whole population sample of Alzheimer's disease with donepezil over a 4-year period: lessons learned. [2008]
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. [2008]
Defining treatment response to donepezil in Alzheimer's disease: responder analysis of patient-level data from randomized, placebo-controlled studies. [2008]
The use of truncated area under the curves in the bioequivalence evaluation of long half-life drugs. Studies with donepezil and memantine. [2008]
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. [2007.12.19]
A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss. [2007.12]
Donepezil for the treatment of agitation in Alzheimer's disease. [2007.10.04]
[Clinical study of combined treatment with compound Reinhartdt and Sea Cumber Capsule and donepezil for vascular dementia] [2007.10]
No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia. [2007.09]
No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia. [2007.09]
Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. [2007.08.10]
Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease. [2007.08]
Donepezil preserves cognition and global function in patients with severe Alzheimer disease. [2007.07.31]
Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/Practice Effects in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. [2007.07.11]
A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy. [2007.07]
Does the cholinesterase inhibitor, donepezil, benefit both declarative and non-declarative processes in mild to moderate Alzheimer's disease? [2007.07]
Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study. [2007.07]
A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia. [2007.06]
A Randomized, Double-Blind, Placebo-Controlled Trial of Donepezil to Improve Memory in Epilepsy. [2007.05.01]
A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. [2007.04]
Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study. [2007.04]
Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study. [2007.01]
Effects of Donepezil Adjunctive Treatment to Ziprasidone on Cognitive Deficits in Schizophrenia: A Double-blind, Placebo-Controlled Study. [2007]
Atypical antipsychotics and pituitary neoplasms in the WHO database. [2007]
A randomized, placebo-controlled study of donepezil in poststroke aphasia. [2006.11.14]
The effect of donepezil on sleep in elderly, healthy persons: a double-blind placebo-controlled study. [2006.11]
Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment. [2006.10]
Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis. [2006.10]
Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease. [2006.10]
Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder. [2006.10]
A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. [2006.09.27]
Therapeutic and prophylactic utility of the memory-enhancing drug donepezil hydrochloride on cognition of patients undergoing electroconvulsive therapy: a randomized controlled trial. [2006.09]
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. [2006.09]
Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study. [2006.09]
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. [2006.07.11]
Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. [2006.07]
Effects of donepezil on memory and cognition in multiple sclerosis. [2006.06.15]
Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers. [2006.06]
A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. [2006.05]
Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. [2006.04.01]
[Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial] [2006.04]
Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study. [2006.04]
Donepezil effects on cerebral blood flow in older adults with mild cognitive deficits. [2006.03]
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease. [2006.03]
The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study. [2006.02.01]
A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania. [2006.02]
Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease. [2006]
3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy. [2006]
Donepezil in the prevention and treatment of post-surgical delirium. [2005.12]
Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study. [2005.10]
Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial. [2005.09]
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period. [2005.08]
Efficacy and tolerability of low-dose donepezil in schizophrenia. [2005.07]
Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. [2005.07]
Vitamin E and donepezil for the treatment of mild cognitive impairment. [2005.06.09]
Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial. [2005.06]
Neuropsychological test performance in healthy elderly volunteers before and after donepezil administration: a randomized, controlled study. [2005.04]
[Donepezil in patients with Alzheimer's disease--a critical appraisal of the AD2000 study] [2005.03.15]
The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease. [2005.03]
A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. [2005.03]
Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. [2005.01]
Donepezil in vascular dementia: combined analysis of two large-scale clinical trials. [2005]
Do vascular lesions and related risk factors influence responsiveness to donepezil chloride in patients with Alzheimer's disease? [2005]
Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial. [2004.12]
Donepezil improved memory in multiple sclerosis in a randomized clinical trial. [2004.11.09]
An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting. [2004.11]
Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. [2004.11]
Repeated dosing with donepezil does not affect the safety, tolerability or pharmacokinetics of single-dose thioridazine in young volunteers. [2004.11]
Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: assessment of pharmacokinetic changes and safety following single and multiple oral doses. [2004.11]
Effects of cognitive-communication stimulation for Alzheimer's disease patients treated with donepezil. [2004.10]
Representation of patients with dementia in clinical trials of donepezil. [2004.09]
Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. [2004.08.24]
Economic evaluation of donepezil in moderate to severe Alzheimer disease. [2004.08.24]
Impact of donepezil treatment for Alzheimer's disease on caregiver time. [2004.08]
The effects of Donepezil on traumatic brain injury acute rehabilitation outcomes. [2004.08]
The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. [2004.07.27]
Donepezil as an adjuvant to constraint-induced therapy for upper-limb dysfunction after stroke: An exploratory randomized clinical trial. [2004.07]
Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study. [2004.07]
Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. [2004.07]
|
